![](https://aiolux-shared.s3.us-east-2.amazonaws.com/aiolux-logo-mid.png)
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[ADAP] Adaptimmune Therapeutics plc - Total Non-Current Assets
Data updated 2024-Mar-23 (Saturday)Note: Detailed Statistics for Total Non-Current Assets in Balance Sheet for Adaptimmune Therapeutics plc [NASDAQ:ADAP] with frequency distribution chart that analyze trends & history . Total Non-Current Assets is the aggregate of assets intended to held by the Company for long term (> 1 year). View Balance Sheet for broader context
Share
Quarterly Total Non-Current Assets values for Adaptimmune Therapeutics plc are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Total Non-Current Assets | 75.1 M | 77.3 M | 81.2 M | 74.3 M | 73.5 M | 68.1 M |
Sequential Quarter Growth | -2.9% | -4.9% | +9.3% | +1.1% | +8.1% | +1.4% |
Quarter-on Quarter Growth | +2.1% | +13.5% | +21.0% | +23.2% | +36.0% | +28.2% |
Annual Total Non-Current Assets values for Adaptimmune Therapeutics plc are rounded to enhance readability
2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|---|
Total Non-Current Assets | 75.1 M | 73.5 M | 54.1 M | 53 M | 61.1 M | 45.6 M |
Year-on-Year Growth | +2.1% | +36.0% | +2.1% | -13.2% | +33.8% | -10.4% |
2-yr CAGR | +17.8% | +17.8% | -5.9% | +7.8% | +9.5% | +13.0% |
3-yr CAGR | +12.3% | +6.4% | +5.8% | +1.3% | +19.5% | |
4-yr CAGR | +5.3% | +12.7% | +1.5% | +10.3% | ||
5-yr CAGR | +10.5% | +7.6% | +8.6% |
Frequency distribution of quarterly Total Non-Current Assets values from 2015-Sep-30 grouped into buckets. Latest Total Non-Current Assets value is 75.1 Million as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for Adaptimmune Therapeutics plc mapped with quarterly Total Non-Current Assets values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Total Non-Current Assets above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Adaptimmune Therapeutics plc with subsequent post-earnings performance given Total Non-Current Assets values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Total Non-Current Assets - Low | 38% | 62% |
Total Non-Current Assets - Medium | 56% | 44% |
Total Non-Current Assets - High | 61% | 39% |
Total Non-Current Assets (Sequential growth %) - Low | 56% | 44% |
Total Non-Current Assets (Sequential growth %) - Medium | 52% | 48% |
Total Non-Current Assets (Sequential growth %) - High | 41% | 59% |
Total Non-Current Assets (QoQ growth %) - Low | 61% | 39% |
Total Non-Current Assets (QoQ growth %) - Medium | 57% | 43% |
Total Non-Current Assets (QoQ growth %) - High | 35% | 65% |
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2024-Jun-21 on Google
SEC Reports : Quarterly reports around 2024-Jun-21 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc